| Detected | Trial | Change |
|---|---|---|
| 2026-05-30 | NCT06508749 The Tatelo Plus Study |
date change Primary completion moved earlier: 2027-11-05 -> 2027-09-03 |
| 2026-05-30 | NCT06508749 The Tatelo Plus Study |
date change Completion moved earlier: 2028-04-21 -> 2028-02-18 |
| 2026-05-30 | NCT04983030 Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and… |
Trial completed |
| 2026-05-30 | NCT04983030 Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and… |
Enrollment reduced: 36 -> 28 participants |
| 2026-05-30 | NCT04983030 Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and… |
date change Completion moved earlier: 2026-04-30 -> 2026-02-23 |
| 2026-05-29 | NCT07215468 HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT07215468 HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study |
Enrollment increased: 75 -> 88 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06812494 | A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal… | HIV | Recruiting |
| NCT05719441 | A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies… | Acute HIV Infection | Recruiting |
| NCT07215468 | HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study | HIV -1 Infection | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT02140255 | Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission | HIV Infection | Recruiting |
| NCT06508749 | The Tatelo Plus Study | HIV | Recruiting |
| Phase 1 | |||
| NCT07390955 | A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult… | HIV | Recruiting |
| NCT06517693 | Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With… | HIV-1 | Recruiting |
| NCT06987318 | A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies… | HIV-1-infection | Not Yet Recruiting |
| NCT05890963 | 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults | HIV-1-infection | Active, Not Recruiting |